INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Artificial intelligence-macine learning-GettyImages-1368016158]( "How AI Is Reshaping Trial Design, Execution, And Disclosure")
How AI Is Reshaping Trial Design, Execution, And DisclosureAI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
-
![citeline precision webinar]( "Where Precision Drives Progress: Meeting The Rising Complexity Of Modern Clinical Trials")
Where Precision Drives Progress: Meeting The Rising Complexity Of Modern Clinical TrialsDiscover how leading teams are using trusted data and targeted AI to design, plan, and execute clinical trials with the confidence today's science requires.
-
![GettyImages-2223908587-doctor-patient]( "Ophthalmology Patient Engagement And Retention: Point-Of-Need Execution")
Ophthalmology Patient Engagement And Retention: Point-Of-Need ExecutionDropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.
-
![The Secret Sauce]( "The Secret Sauce Behind High-Enrolling PIs")
The Secret Sauce Behind High-Enrolling PIsThe real challenge with enrollment often comes at the screening stage, where PI prioritization, site bandwidth, and sponsor support guide how many patients actually make it onto a study.
-
Practical Strategies For Diverse Trial Recruitment11/11/2024
The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.
-
ISPOR Top 10 HEOR Trends: What Are The Key Themes For 2026-27?9/22/2026
Healthcare decision-making is evolving fast. Discover how AI, RWE, and changing HTA frameworks are influencing pricing, patient engagement, and market access.
-
The Future Of Patient Recruitment: Leveraging RWD For Precision4/25/2025
To combat the costly challenges of patient recruitment and keep trials on track, sponsors can leverage real-world data.
-
Capital Efficiency In Cardiovascular Outcomes Trials7/8/2026
New modeling shows aligning clinical and manufacturing operations in heart trials can cut costs, speed timelines, and boost expected program value.
-
Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors7/17/2026
Biomarkers and other specialty lab samples are among the most fragile parts of clinical trial execution, but what makes them so vulnerable to mishandling, and what are the effects?
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1302454470 drug review]( "Why Central IRBs Matter For Efficient Clinical Trials")
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC ServicesFast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
-
![GettyImages-1819626829 patient recruitment]( "Precision Recruitment Is the Name of the Game")
Leverage an exhaustive view of patients, diseases, and providers to precisely identify protocol-specific populations within a sponsor’s site network.
-
![logistics-discovery-transport-travel-GettyImages-1287428874]( "Safe-To-Site: Confidence In Clinical Trial Travel")
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
![GettyImages-1492337134 doctor notes]( "Clinical Operations And Project Management")
Consider the benefits of an integrated operations and project management approach across all phases and regions.
-
![GettyImages-1325251634-doctor-patient-blood-pressure-visit]( "Recruitment Strategies: A Behind The Scenes Look")
Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
